HON is showing one of the worst 1-month figures in Stoxcraft's Top 50 right now. Down 46% in a month. Down 49.3% over three months. Down 51.7% year-over-year. The stock closed at $231.18 on July 7. That's 8.3% below its 52-week high.
Those two facts don't belong in the same sentence unless you know what happened on June 29.
What Honeywell actually did on June 29
Honeywell spent two years breaking itself into three companies. On June 29, the final step closed. Honeywell Aerospace Inc. became a standalone public entity, and every HON shareholder received shares in it automatically. Solstice Advanced Materials also separated in the same process.
Price charts still use the pre-split share price as their baseline. Any return figure spanning June 29 compares today's smaller Honeywell against the combined entity it used to be. The gap between those two prices isn't a loss. It's where the aerospace business went.
Think of it like a video game character splitting their stat points across two new characters. Each starts lower than the original. Combined, the total is roughly the same.
Panic-selling investors
77%
of investors regret panic-selling during crises
Why HON's scores look the way they do right now
The Performance Score is 0.0 out of 10. That number is a direct consequence of the data artifact, not an assessment of operations. The return series compares today's price to a history that includes a company twice its current size. It'll normalize as the adjusted figures catch up over the coming months.
The Risk Score tells a different story. At 3.7 out of 10, where a higher score means more risk, HON sits well into low-to-moderate territory. The drawdown data and volatility readings feeding that score aren't flashing distress signals. They're reading like a large-cap industrial mid-restructuring.
The RSI of 19.1 is deeply oversold. Below 30 is the threshold. A reading this low means the price has been pushed down hard and fast, often faster than fundamentals justify. A stock sitting 8.3% off its 52-week high with an RSI of 19.1 is a timing signal, not a fundamental one.
The Health Score of 5.7 out of 10 is the most grounded number in the set. It places HON above roughly half of all Industrials names in the Stoxcraft universe, mid-pack by design. Solid free cash flow, reasonable leverage, and the friction that comes with restructuring a three-way split of this complexity.
What analysts are pricing into HON after the split
The consensus price target sits at $251.08 against a July 7 close of $231.18. That's 8.6% implied upside. Analysts haven't revised targets down following the spinoff close.
The dividend yield on the restructured company stands at 1.97%. Real income on a smaller company. That signals management expects HON to generate enough cash to sustain payouts while integrating the split.
The P/E ratio of 25.8x is above the Industrials norm, reflecting an expectation that the refocused HON, now concentrated in building technologies and performance materials, grows faster than the sector baseline. Per Reuters' coverage of the Honeywell restructuring, the separation was the final step in a multi-year plan to focus each entity on its core market.
For context on the broader industrial and defense space, RTX (RTX) and LMT (LMT) carry different score profiles and multiples. Both will appear in Stoxcraft's upcoming Aerospace and Defense sector report.
HON vs. the Industrials sector right now
A typical mid-pack Industrials name carries a Health Score in the 5 to 6 range and a Performance Score reflecting its actual return history. HON has the same Health Score but a zeroed-out Performance figure. The Risk Score sits below the sector average. That combination doesn't read like a genuine breakdown in the data.
HON fits a recognisable setup in the Stoxcraft data
This is a Turnaround Candidate pattern, with one key difference. The Performance Score and trend signal are weak because the company restructured, not because the business failed. The fundamentals, as captured by the Health Score, are still standing. The Risk Score is suppressed.
The recovery clock started June 29. This setup doesn't need a fix. It needs time.
HON: the Health Score is the number to watch
The 2-star overall rating is being pulled down almost entirely by the Performance Score artifact. That changes as the adjusted return history normalises.
The first earnings report from HON as a standalone building technologies and performance materials company is the real test. That's when the market gets a clean P&L without the aerospace numbers in the mix. Until then, 1M/3M/1Y figures anywhere you look will keep showing numbers that don't match the underlying picture.
The stock is 8.3% off its high. The Health Score is mid-pack, not deteriorating. The Risk Score is low-to-moderate. When the Performance Score catches up, the overall rating will follow.
